Renascience is a Japanese biotech venture company engaged in the research and development of multiple modalities — including small molecule drugs, medical devices, and AI-powered software as medical devices (SaMD) — targeting aging-related diseases (NCDs such as cancer, diabetes, respiratory, and cardiovascular diseases) as well as women's and pediatric health conditions. The company operates an asset-light, open-innovation model, leveraging physician-scientists at partner universities (including Tohoku University and Hiroshima University) to conduct physician-initiated clinical trials from basic research through Phase III studies. Its business model focuses on advancing pipeline assets to late-stage development before out-licensing to major pharmaceutical companies, with the aim of generating significant licensing revenues.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →Renascience is a Japanese biotech venture company engaged in the research and development of multiple modalities — including small molecule drugs, medical devices, and AI-powered software as medical devices (SaMD) — targeting aging-related diseases (NCDs such as cancer, diabetes, respiratory, and cardiovascular diseases) as well as women's and pediatric health conditions. The company operates an asset-light, open-innovation model, leveraging physician-scientists at partner universities (including Tohoku University and Hiroshima University) to conduct physician-initiated clinical trials from basic research through Phase III studies. Its business model focuses on advancing pipeline assets to late-stage development before out-licensing to major pharmaceutical companies, with the aim of generating significant licensing revenues.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →